Triumph Capital Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.93K Hold
1,715
– – ﹤0.01% 1339
2026
Q2
$7.92K Hold
1,715
– – ﹤0.01% 1213
2026
Q1
$8.1K Hold
1,715
– – ﹤0.01% 1171
2025
Q4
$8.58K Buy
+1,715
New +$8.93K ﹤0.01% 1126
2024
Q2
– Sell
-42,991
Closed -$194K – 264
2024
Q1
$194K Buy
42,991
+8,729
+25% +$33.4K 0.08% 213
2023
Q4
$174K Buy
34,262
+7,288
+27% +$35.7K 0.07% 206
2023
Q3
$151K Sell
26,974
-38,366
-59% -$307K 0.07% 209
2023
Q2
$625K Buy
+65,340
New +$553K 0.28% 76
2023
Q1
– Sell
-15,815
Closed -$176K – 214
2022
Q4
$176K Buy
+15,815
New +$184K 0.09% 194

Other funds holding MPT

Triumph Capital Management's MPT Position: Q3 2026 in Review

Triumph Capital Management held its Medical Properties Trust (MPT) position steady in Q3 2026 at 1,715 shares worth $5.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1339.

Triumph Capital Management first reported a position in MPT in Q4 2022 and has held it in 9 quarters since. The position peaked at $625K in Q2 2023. 239 funds tracked by Wall St. Rank hold MPT as of Q3 2026.

  • Triumph Capital Management held 1,715 shares of Medical Properties Trust worth $5.93K as of Q3 2026.
  • Triumph Capital Management left its Medical Properties Trust share count unchanged in Q3 2026.
  • Medical Properties Trust made up ﹤0.01% of Triumph Capital Management's portfolio in Q3 2026, its #1339 holding.
  • Triumph Capital Management first reported a position in Medical Properties Trust in Q4 2022 and has held it in 9 quarters since.
  • Triumph Capital Management's Medical Properties Trust position peaked at $625K in Q2 2023.
  • 239 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2026.

Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.